Quantum Biopharma (QNTM) Cash & Current Investments (2018 - 2026)

Quantum Biopharma has disclosed Cash & Current Investments across 9 years of filings, most recently posting $2.1 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $2.1 million, down 64.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 64.63% YoY), and the FY2025 annual result was $2.4 million, down 67.15% from the prior year.
• Cash & Current Investments came in at $2.1 million for Q1 2026 at Quantum Biopharma, down from $2.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $35.8 million in Q1 2022 to a low of $2.1 million in Q1 2026.
• The 5-year median for Cash & Current Investments is $6.4 million (2024), against an average of $12.2 million.
• Across the five-year window, Cash & Current Investments plunged 82.27% in 2023 and jumped 120.0% in 2025, its largest moves.
• Quantum Biopharma's Cash & Current Investments stood at $17.0 million in 2022, then gained by 4.36% to $17.7 million in 2023, then plunged by 59.38% to $7.2 million in 2024, then slumped by 67.15% to $2.4 million in 2025, then retreated by 9.99% to $2.1 million in 2026.
• The last three Cash & Current Investments figures came in at $2.1 million (Q1 2026), $2.4 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.